The digital transformation of pharma’s physician engagement strategies
The exact shape of healthcare’s post-COVID ‘new normal’ is still being framed, but it is clear that some trends are already taking shape - and one of the key ones is digital transformation in pharma.
The pandemic has ushered in a number of major changes to healthcare systems, notably in the ways in which pharmaceutical companies communicate, visit and engage with physicians.
In doing so it’s compounded pre-existing pressure with pharma, where schedules are shrinking and policies are often already restrictive enough to build barriers for effective physician engagement. The threat of disease spread and other risk factors from COVID-19 have only compounded this.
This pharmaphorum webinar, held in association with P360, takes place on Wednesday 19th May 08:00 PST / 16:00 BST / 17:00 CET and will look at the long-term implications of healthcare’s pandemic-powered digital transformation.
Focus
The webinar will also cover:
- How HCP engagement changed for pharma in 2020
- How engagement with HCPs will evolve in the future
- HCP perspective on how they would like to engage with pharma, now and in the future
- The role technology will play in bridging the gap between pharma and HCPs
View the webinar* by clicking on the link in the window above or by clicking here.
Our Panel
Anupam Nandwana, CEO and Founder of P360, is an executive focused on digital transformation for the life sciences industry. His vision is to transform the way businesses operate by helping them increase speed to market while also improving patient care. P360 helps life sciences organisations work smarter and more efficiently with technologies that include artificial intelligence (AI), machine learning, the Internet of Things (IoT), sales enablement and more. Mr. Nandwana has been in the life sciences field since 1996 and has a Bachelor of Science in Mechanical Engineering from the University of Mumbai. Follow him on Twitter or connect with him on LinkedIn.
Florent Edouard is the global head of commercial excellence at Grünenthal Group, a pharmaceutical company headquartered in Germany and specialised in pain. Coming from AstraZeneca, where he led multiple commercial functions including four years in charge of AZ Respiratory and GI franchise in Japan, he joined Grünenthal in 2017 to drive the company’s commercial transformation, from Launch Excellence to Field team impact, through Analytics uplift as well as platform and capability build across affiliates.
Dr Mandira N. Mehra is a double board certified physician. Aside from being a medical doctor she is a published medical journalist and television medical correspondent. She is routinely seen on CBS, FOX 5, NBC, ABC and MHz Networks. She is founder and host of the podcast and television segment "Human Condition MD". She graduated from George Washington University School Of Medicine in 2010.
Catherine Longworth, web editor, pharmaphorum, [moderator] Catherine Longworth is the web editor for pharmaphorum media, leading healthcare features coverage. Based in London, Catherine has international experience and reported from across Europe, the U.S and Israel. She is regularly invited to speak and moderate at industry events. Catherine previously worked for Informa’s Pharma Intelligence division where she covered the medical technology and digital health sectors. She has a first-class degree in Biomedical Science from St. George’s University of London, and a diploma in journalism from Britain’s National Council for the Training of Journalists.
